Home/ Stocks/ RNAC

Cartesian Therapeutics, Inc. Common Stock

RNAC XNAS

$8.85 -0.08 (-0.91%) ▼ 15-min delayed

Open

$8.88

High

$8.95

Low

$8.62

Volume

83.8K

Market Cap

$265.04M

About Cartesian Therapeutics, Inc. Common Stock

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 75 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$2.80M	$-130,302,000	$-5.02
FY 2025	$2.80M	$-130,302,000	$-5.02
Q3 2025	$452.0K	$-35,902,000	$-1.38
Q2 2025	$298.0K	$15.89M	$0.51

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for RNAC yet. Check out our latest market news or earnings calendar.

Get RNAC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cartesian Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.